Gene therapy in gastroenterology.

Por Pandha, H S, Lemoine, N R
Publicado em 1996

Detection of T Cell Cytokine Production as a Tool for Monitoring Immunotherapy

Por John, J., Pandha, H., Dalgleish, A. G.
Publicado em 2000

Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines

Por Pandha, H, Rigg, A, John, J, Lemoine, N
Publicado em 2007

Failure of normalisation of alpha fetoprotein concentration after successful treatment of teratoma.

Por Pandha, H. S., Wasan, H. S., Harrington, K., Waxman, J.
Publicado em 1995

Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Por TODRYK, S, CHONG, H, VILE, R, PANDHA, H, LEMOINE, N
Publicado em 1998

HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)

Por Plowright, L, Harrington, K J, Pandha, H S, Morgan, R
Publicado em 2009

Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy

Por Ismail, M, Bokaee, S, Davies, J, Harrington, K J, Pandha, H
Publicado em 2009

Secretory symptoms from metastatic adrenal cortical carcinoma responding to octreotide.

Por Pandha, H. S., Harrington, K., Saini, S., Lynn, J., Peters, M., Waxman, J.
Publicado em 1995

Cancer in Blacks, Whites and Asians in a British Hospital

Por Potter, J. F., Dawkins, D. M., Pandha, H. S., Beevers, D. G.
Publicado no J R Coll Physicians Lond (1984)

Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy

Por Ismail, M, Bokaee, S, Morgan, R, Davies, J, Harrington, K J, Pandha, H
Publicado em 2009

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics

Por Harrington, K.J., Vile, R.G., Melcher, A., Chester, J., Pandha, H.S.
Publicado em 2010

P01.04 THERAPEUTIC POTENTIAL OF TARGETING HOX PROTEIN FUNCTION IN GLIOBLASTOMA

Por Brend, T., Kelly, Z., Ajaz, M., Morgan, R., Pandha, H., Short, S.C.
Publicado em 2014

Locoregional intravascular viral therapy of cancer: precision guidance for Paris’s arrow?

Por Pencavel, T, Seth, R, Hayes, A, Melcher, A, Pandha, H, Vile, R, Harrington, KJ
Publicado em 2010

The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressors

Por STEBBING, J, BOWER, M, GAZZARD, B, WILDFIRE, A, PANDHA, H, DALGLEISH, A, SPICER, J
Publicado em 2004

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

Por Hingorani, M., Spitzweg, C., Vassaux, G., Newbold, K., Melcher, A., Pandha, H., Vile, R., Harrington, K.
Publicado em 2010

Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming

Por Merrick, A, Errington, F, Milward, K, O'Donnell, D, Harrington, K, Bateman, A, Pandha, H, Vile, R, Morrison, E, Selby, P, Melcher, A
Publicado em 2005

Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer

Por Simpson, G R, Horvath, A, Annels, N E, Pencavel, T, Metcalf, S, Seth, R, Peschard, P, Price, T, Coffin, R S, Mostafid, H, Melcher, A A, Harrington, K J, Pandha, H S
Publicado em 2012

Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites

Por Jennings, VA, Ilett, EJ, Scott, KJ, West, EJ, Vile, R, Pandha, H, Harrington, K, Young, A, Hall, GD, Coffey, M, Selby, P, Errington-Mais, F, Melcher, AA
Publicado no Int J Cancer (2014)

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced...

Por Bartlett, J B, Michael, A, Clarke, I A, Dredge, K, Nicholson, S, Kristeleit, H, Polychronis, A, Pandha, H, Muller, G W, Stirling, D I, Zeldis, J, Dalgleish, A G
Publicado em 2004

Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer

Por Annels, N E, Simpson, G R, Denyer, M, McGrath, S E, Falgari, G, Killick, E, Eeles, R, Stebbing, J, Pchejetski, D, Cutress, R, Murray, N, Michael, A, Pandha, H
Publicado no Clin Exp Immunol (2014)